fluoxetine has been researched along with Autotomy Human in 13 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-two patients meeting the criteria for borderline or schizotypal personality disorder or both participated in a prospective, nonblind 12-week trial of fluoxetine." | 9.07 | Fluoxetine in the treatment of borderline and schizotypal personality disorders. ( Calabrese, JR; Markovitz, PJ; Meltzer, HY; Schulz, SC, 1991) |
| "Twenty-two patients meeting the criteria for borderline or schizotypal personality disorder or both participated in a prospective, nonblind 12-week trial of fluoxetine." | 5.07 | Fluoxetine in the treatment of borderline and schizotypal personality disorders. ( Calabrese, JR; Markovitz, PJ; Meltzer, HY; Schulz, SC, 1991) |
| "Self-injurious ideation or behavior appeared de novo or intensified during fluoxetine treatment of obsessive-compulsive disorder in six patients, age 10 to 17 years old, who were among 42 young patients receiving fluoxetine for obsessive-compulsive disorder at a university clinical research center." | 3.68 | Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. ( Anderson, GM; Chappell, PB; Hardin, MT; King, RA; Lombroso, P; Riddle, MA; Scahill, L, 1991) |
| "Risk factors such as borderline personality disorder and childhood abuse experiences were systematically assessed, and patients were genotyped for polymorphisms of GNbeta3." | 2.72 | Genetic, developmental and personality correlates of self-mutilation in depressed patients. ( Joyce, PR; Kennedy, MA; Luty, SE; McKenzie, JM; Miller, AL; Mulder, RT; Sullivan, PF, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cravero, C | 1 |
| Guinchat, V | 1 |
| Barete, S | 1 |
| Consoli, A | 1 |
| Sharma, H | 1 |
| Kasim, S | 1 |
| Egami, K | 1 |
| Jinnah, HA | 1 |
| Yanik, M | 1 |
| San, I | 1 |
| Alatas, N | 1 |
| Joyce, PR | 1 |
| McKenzie, JM | 1 |
| Mulder, RT | 1 |
| Luty, SE | 1 |
| Sullivan, PF | 1 |
| Miller, AL | 1 |
| Kennedy, MA | 1 |
| Brown, K | 1 |
| Henderson, T | 1 |
| Velazquez, L | 1 |
| Ward-Chene, L | 1 |
| Loosigian, SR | 1 |
| Warnock, JK | 1 |
| Kestenbaum, T | 1 |
| Markovitz, PJ | 1 |
| Calabrese, JR | 1 |
| Schulz, SC | 1 |
| Meltzer, HY | 1 |
| King, RA | 1 |
| Riddle, MA | 1 |
| Chappell, PB | 1 |
| Hardin, MT | 1 |
| Anderson, GM | 1 |
| Lombroso, P | 1 |
| Scahill, L | 1 |
| Markowitz, PI | 1 |
| Hollander, E | 1 |
| Papp, L | 1 |
| Campeas, R | 1 |
| DeCaria, C | 1 |
| Liebowitz, MR | 1 |
| Primeau, F | 1 |
| Fontaine, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Genetics of Self-injurious Behaviour[NCT05563324] | 234 participants (Actual) | Observational | 2014-05-09 | Completed | |||
| Influences on and Prevention of Self-harm Behaviour Among the Most At-risk Adolescents[NCT05765864] | 400 participants (Anticipated) | Observational | 2023-03-23 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for fluoxetine and Autotomy Human
| Article | Year |
|---|---|
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl | 2006 |
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl | 2006 |
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl | 2006 |
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl | 2006 |
Fluoxetine in the treatment of borderline and schizotypal personality disorders.
Topics: Adult; Borderline Personality Disorder; Chronic Disease; Drug Administration Schedule; Female; Fluox | 1991 |
More on self mutilation and obsessive compulsive disorder.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Fluoxetine; Humans; Male; Obsessive-Compulsive | 1988 |
10 other studies available for fluoxetine and Autotomy Human
| Article | Year |
|---|---|
Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes.
Topics: Adult; Anemia, Iron-Deficiency; Antidepressive Agents, Second-Generation; Cognitive Behavioral Thera | 2016 |
Psychogenic excoriation responding to fluoxetine: a case report.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Behavior Therapy; Clomipramine; Compulsive Beh | 2008 |
Self-biting induced by activation of L-type calcium channels in mice: serotonergic influences.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2002 |
A case of factitious disorder involving menstrual blood smeared on the face.
Topics: Adult; Antipsychotic Agents; Culture; Factitious Disorders; Female; Fluoxetine; Humans; Menstruation | 2004 |
Blood-letting in bulimia nervosa.
Topics: Adult; Bloodletting; Bulimia; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Self Mut | 1993 |
Fluoxetine in the treatment of self-mutilating behavior.
Topics: Adolescent; Child; Child, Preschool; Disruptive, Impulse Control, and Conduct Disorders; Fluoxetine; | 2000 |
Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports.
Topics: Adult; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Prader-Willi Syndrome; Self | 1992 |
Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.
Topics: Adolescent; Age Factors; Child; Clinical Trials as Topic; Double-Blind Method; Female; Fluoxetine; H | 1991 |
Fluoxetine treatment of self-injurious behavior in mentally retarded patients.
Topics: Adult; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Mental Disorders; Middle | 1990 |
Obsessive disorder with self-mutilation: a subgroup responsive to pharmacotherapy.
Topics: Adult; Clomipramine; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Propylamines; | 1987 |